Generic drugmaker Sandoz to engage with US after Trump tariff threat

US President Donald Trump threatened steep tariffs on generic drugmakers. He stated medicines must be manufactured locally or face significant import duties. Swiss firm Sandoz will continue discussions with policymakers on this matter. The company is assessing implications for its manufacturing operations and future investments. This move aims to reverse offshore production and could increase drug prices.